Baillieu Research released a report yesterday.
In short they maintain a "Hold", but have upgraded their price target from $1.36 to $1.50. They continue to exclude any revenue from the hernia repair product in their forecasts despite the plans for it to be launched next year. A conservative approach indeed.
Investment view: HOLD maintained. Revised DCF valuation (prev. A$1.36) and price target (prev. A$1.35) of A$1.50 – we have included FY22 forecasts in our valuation which has been rolled forward. The absence of a BUY call is solely valuation related. Whilst investors should consider the current share price versus their respective entry price, we view PNV as a keeper given: 1) BTM commercialisation has been franked; 2) market disruption is likely to attract M&A; 3) heavy commitments for R&D/trials continue to be underwritten by third party sponsors/partners; 4) proximity of the mid-2020 launch of the hernia repair application, which does not require further regulatory approval in the US; and 5) other product applications, which are in larger addressable markets, are yet to be considered in our forecasts and valuation.
- Forums
- ASX - By Stock
- Broker upgrade
Baillieu Research released a report yesterday. In short they...
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B |
Open | High | Low | Value | Volume |
$2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 35541 | $2.45 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.46 | 2681 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8773 | 2.450 |
3 | 6522 | 2.430 |
1 | 2681 | 2.420 |
3 | 6302 | 2.410 |
3 | 5925 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.460 | 2681 | 1 |
2.470 | 2681 | 1 |
2.480 | 23333 | 3 |
2.490 | 12681 | 2 |
2.500 | 92672 | 4 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online